Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | YTHDC1 | Q96MU7 | 2/20 | 0.51 |
| ▸ | CHKA | P35790 | 3/20 | 0.49 |
| ▸ | CHKB | Q9Y259 | 2/20 | 0.49 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.48 |
| ▸ | FLT3 | P36888 | 4/20 | 0.47 |
| ▸ | SRC | P12931 | 2/20 | 0.46 |
| ▸ | CDK2 | P24941 | 4/20 | 0.45 |
| ▸ | PDGFRA | P16234 | 3/20 | 0.45 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.44 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.44 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.44 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.43 |
| ▸ | AURKA | O14965 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5629622 | 0.91 | NPC1 (0.52) | NPC1YTHDC1CHKACHKBADORA3 | |
| SCHEMBL5194104 | 0.90 | NPC1 (0.58) | NPC1YTHDC1CHKACHKBADORA3 | |
| SCHEMBL5195286 | 0.89 | NPC1 (0.57) | NPC1YTHDC1CHKACHKBADORA3 | |
| SCHEMBL5629791 | 0.81 | ADORA3 (0.47) | NPC1ADORA3FLT3SRCCDK2 | |
| SCHEMBL6944005 | 0.81 | NPC1 (0.62) | NPC1ADORA3FLT3SRCCDK2 | |
| SCHEMBL5196709 | 0.81 | NPC1 (0.49) | NPC1YTHDC1ADORA3FLT3SRC | |
| SCHEMBL6574798 | 0.81 | YTHDC1 (0.64) | NPC1YTHDC1 | |
| SCHEMBL5194070 | 0.81 | FLT3 (0.64) | NPC1FLT3SRCCDK2PDGFRA | |
| SCHEMBL5626392 | 0.80 | FLT3 (0.55) | NPC1ADORA3FLT3SRCCDK2 | |
| SCHEMBL5192781 | 0.79 | NPC1 (0.62) | NPC1YTHDC1FLT3SRCCDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7208598-B2 | Derivatives of purine, their preparation process and pharmaceutical compositions containing them | AVENTIS PHARMA (FR) | 2007-04-24 | — | — | US | disclosed |
| US-7122669-B1 | Purine derivatives, preparation method and pharmaceutical compositions containing same | HOECHST MARION ROUSSEL (FR) | 2006-10-17 | — | — | US | disclosed |
| US-20050187228-A1 | Derivatives of purine, their preparation process and pharmaceutical compositions containing them | AVENTIS PHARMA S.A. | 2005-08-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050187228-A1 | Derivatives of purine, their preparation process and pharmaceutical compositions containing them | CDK6, CDK1, CDK2 | NPC1 3546/4885YTHDC1 2177/4885CHKA 933/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.